Spinal involvement in mucopolysaccharidosis IVA (Morquio-Brailsford or Morquio A syndrome): presentation, diagnosis and management
- PMID: 23385297
- PMCID: PMC3590412
- DOI: 10.1007/s10545-013-9586-2
Spinal involvement in mucopolysaccharidosis IVA (Morquio-Brailsford or Morquio A syndrome): presentation, diagnosis and management
Abstract
Mucopolysaccharidosis IVA (MPS IVA), also known as Morquio-Brailsford or Morquio A syndrome, is a lysosomal storage disorder caused by a deficiency of the enzyme N-acetyl-galactosamine-6-sulphate sulphatase (GALNS). MPS IVA is multisystemic but manifests primarily as a progressive skeletal dysplasia. Spinal involvement is a major cause of morbidity and mortality in MPS IVA. Early diagnosis and timely treatment of problems involving the spine are critical in preventing or arresting neurological deterioration and loss of function. This review details the spinal manifestations of MPS IVA and describes the tools used to diagnose and monitor spinal involvement. The relative utility of radiography, computed tomography (CT) and magnetic resonance imaging (MRI) for the evaluation of cervical spine instability, stenosis, and cord compression is discussed. Surgical interventions, anaesthetic considerations, and the use of neurophysiological monitoring during procedures performed under general anaesthesia are reviewed. Recommendations for regular radiological imaging and neurologic assessments are presented, and the need for a more standardized approach for evaluating and managing spinal involvement in MPS IVA is addressed.
Conflict of interest statement
G. A. Solanki, K. W. Martin and M. C. Theroux have each received speaker’s honorarium and travel support from BioMarin Pharmaceutical Inc. (BioMarin). C. Lampe has received speaker’s fees, consulting fees, travel support and research grants from BioMarin. K. K. White has received honoraria, research grants and travel support from BioMarin, and is an investigator in MPS IVA clinical trials. R. Shediac is an employee and shareholder of BioMarin. C.G. Lampe and W. G. Mackenzie have received travel support from BioMarin. M. Beck has received speaker’s fees, consulting fees, travel support and unrestricted research grants from Biomarin. C. J. Hendriksz has received consulting fees, symposium support for himself and team personnel, and research grants from BioMarin, and has also been an investigator in MPSIVA clinical trials. P. R. Harmatz has provided consulting support to BioMarin, has received research grants, speaker’s honorarium and travel support from BioMarin, and is an investigator in MPS IVA clinical trials.
Figures
References
-
- Beighton P, Craig J. Atlanto-axial subluxation in the Morquio syndrome. Report of a case. J Bone Joint Surg Br. 1973;55:478–481. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
